RTSN
Retension Pharmaceuticals Inc.
There isn't enough reported data to score RTSN yet.
RTSN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate RTSN's fundamentals.
RTSN PE Valuation
RTSN has no meaningful PE right now: it lost money over the past year.
RTSN Forward outlook
There aren't enough analyst estimates for RTSN to show an outlook.
RTSN Earnings Per Share
RTSN Quarterly Revenue
RTSN Free Cash Flow
RTSN Net Leverage
RTSN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RTSN Weekly Momentum
As of the close on Nov 12, 2026: $12.25.
RTSN PE vs Healthcare Sector
RTSN has no meaningful PE right now: it lost money over the past year.
RTSN Weekly Moving Averages
As of the close on Nov 12, 2026: $12.25.
RTSN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $10.5 | $12.3 | +16% |
It's up 16% so far in 2026.